The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Immune checkpoint inhibitor in high-risk oral potentially malignant disorders (IMPEDE study): An interim analysis on safety.
 
Andrea Alberti
No Relationships to Disclose
 
Chiara Romani
No Relationships to Disclose
 
Alberto Paderno
No Relationships to Disclose
 
Simonetta Battocchio
No Relationships to Disclose
 
Laura Ardighieri
No Relationships to Disclose
 
Consuelo D'Ambrosio
No Relationships to Disclose
 
Raul Pellini
No Relationships to Disclose
 
Giorgio Peretti
No Relationships to Disclose
 
Maria Cossu Rocca
No Relationships to Disclose
 
Mohssen Ansarin
No Relationships to Disclose
 
Paolo Boscolo Rizzo
No Relationships to Disclose
 
Lorenzo Azzi
No Relationships to Disclose
 
Giovanni Lodi
No Relationships to Disclose
 
Carlo Gervasoni
No Relationships to Disclose
 
Stefania Vecchio
No Relationships to Disclose
 
Elena Bardellini
No Relationships to Disclose
 
Alessandra Majorana
No Relationships to Disclose
 
Cesare Piazza
No Relationships to Disclose
 
Fabio Facchetti
No Relationships to Disclose
 
Paolo Bossi
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline; Merck; MSD Oncology; Regeneron
Consulting or Advisory Role - Angelini Pharma; Bristol-Myers Squibb; GlaxoSmithKline; Merck Serono; MSD Oncology; Sanofi/Regeneron; Sun Pharma
Research Funding - Amgen (Inst); GlaxoSmithKline (Inst); Merck Serono (Inst); MSD Oncology (Inst); Regeneron (Inst); Roche (Inst)